Among treated-tumor tissues, the most recurrent mutations were observed in TP53, followed by EGFR (Figure 4), which indicated that EGFR and TP53 were the two most frequently mutated genes in all sample types, as previously reported (16). This evidence concerns the gene EGFR and neoplasm.